-
Something wrong with this record ?
Francisella tularensis type B ΔdsbA mutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody response in vivo
A. Straskova, P. Spidlova, S. Mou, P. Worsham, D. Putzova, I. Pavkova, J. Stulik,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
PubMed Central
from 2014
ProQuest Central
from 2015-01-01 to 1 year ago
Open Access Digital Library
from 1996-01-01
Health & Medicine (ProQuest)
from 2015-01-01 to 1 year ago
Public Health Database (ProQuest)
from 2015-01-01 to 1 year ago
Oxford Journals Open Access Collection
from 2013-02-01
PubMed
26253078
DOI
10.1093/femspd/ftv058
Knihovny.cz E-resources
- MeSH
- Vaccines, Attenuated administration & dosage genetics immunology MeSH
- Bacterial Vaccines administration & dosage genetics immunology MeSH
- Cytokines secretion MeSH
- Virulence Factors deficiency MeSH
- Francisella tularensis classification enzymology immunology MeSH
- Disease Models, Animal MeSH
- Mice, Inbred BALB C MeSH
- Protein Disulfide-Isomerases deficiency MeSH
- Th1 Cells immunology MeSH
- Tularemia immunology prevention & control MeSH
- Antibody Formation * MeSH
- Cross Protection * MeSH
- Animals MeSH
- Check Tag
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Francisella tularensis subspecies tularensis is a highly virulent intracellular bacterial pathogen, causing the disease tularemia. However, a safe and effective vaccine for routine application against F. tularensis has not yet been developed. We have recently constructed the deletion mutants for the DsbA homolog protein (ΔdsbA/FSC200) and a hypothetical protein IglH (ΔiglH/FSC200) in the type B F. tularensis subsp. holarctica FSC200 strain, which exerted different protection capacity against parental virulent strain. In this study, we further investigated the immunological correlates for these different levels of protection provided by ΔdsbA/FSC200 and ΔiglH/FSC200 mutants. Our results show that ΔdsbA/FSC200 mutant, but not ΔiglH/FSC200 mutant, induces an early innate inflammatory response leading to strong Th1-like antibody response. Furthermore, vaccination with ΔdsbA/FSC200 mutant, but not with ΔiglH/FSC200, elicited protection against the subsequent challenge with type A SCHU S4 strain in mice. An immunoproteomic approach was used to map a spectrum of antigens targeted by Th1-like specific antibodies, and more than 80 bacterial antigens, including novel ones, were identified. Comparison of tularemic antigens recognized by the ΔdsbA/FSC200 post-vaccination and the SCHU S4 post-challenge sera then revealed the existence of 22 novel SCHU S4 specific antibody clones.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16020426
- 003
- CZ-PrNML
- 005
- 20160728111042.0
- 007
- ta
- 008
- 160722s2015 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/femspd/ftv058 $2 doi
- 024 7_
- $a 10.1093/femspd/ftv058 $2 doi
- 035 __
- $a (PubMed)26253078
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Straskova, Adela $u Department of Molecular Pathology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Trebesska 1575, Hradec Kralove 500 01, Czech Republic straskova@alga.cz.
- 245 10
- $a Francisella tularensis type B ΔdsbA mutant protects against type A strain and induces strong inflammatory cytokine and Th1-like antibody response in vivo / $c A. Straskova, P. Spidlova, S. Mou, P. Worsham, D. Putzova, I. Pavkova, J. Stulik,
- 520 9_
- $a Francisella tularensis subspecies tularensis is a highly virulent intracellular bacterial pathogen, causing the disease tularemia. However, a safe and effective vaccine for routine application against F. tularensis has not yet been developed. We have recently constructed the deletion mutants for the DsbA homolog protein (ΔdsbA/FSC200) and a hypothetical protein IglH (ΔiglH/FSC200) in the type B F. tularensis subsp. holarctica FSC200 strain, which exerted different protection capacity against parental virulent strain. In this study, we further investigated the immunological correlates for these different levels of protection provided by ΔdsbA/FSC200 and ΔiglH/FSC200 mutants. Our results show that ΔdsbA/FSC200 mutant, but not ΔiglH/FSC200 mutant, induces an early innate inflammatory response leading to strong Th1-like antibody response. Furthermore, vaccination with ΔdsbA/FSC200 mutant, but not with ΔiglH/FSC200, elicited protection against the subsequent challenge with type A SCHU S4 strain in mice. An immunoproteomic approach was used to map a spectrum of antigens targeted by Th1-like specific antibodies, and more than 80 bacterial antigens, including novel ones, were identified. Comparison of tularemic antigens recognized by the ΔdsbA/FSC200 post-vaccination and the SCHU S4 post-challenge sera then revealed the existence of 22 novel SCHU S4 specific antibody clones.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a tvorba protilátek $7 D000917
- 650 _2
- $a bakteriální vakcíny $x aplikace a dávkování $x genetika $x imunologie $7 D001428
- 650 12
- $a zkřížená ochrana $7 D056738
- 650 _2
- $a cytokiny $x sekrece $7 D016207
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a Francisella tularensis $x klasifikace $x enzymologie $x imunologie $7 D005604
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a proteindisulfidisomerasy $x nedostatek $7 D019704
- 650 _2
- $a Th1 buňky $x imunologie $7 D018417
- 650 _2
- $a tularemie $x imunologie $x prevence a kontrola $7 D014406
- 650 _2
- $a atenuované vakcíny $x aplikace a dávkování $x genetika $x imunologie $7 D014613
- 650 _2
- $a faktory virulence $x nedostatek $7 D037521
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Spidlova, Petra $u Department of Molecular Pathology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Trebesska 1575, Hradec Kralove 500 01, Czech Republic.
- 700 1_
- $a Mou, Sherry $u Bacteriology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702-5011, USA.
- 700 1_
- $a Worsham, Patricia $u Bacteriology Division, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702-5011, USA.
- 700 1_
- $a Putzova, Daniela $u Department of Molecular Pathology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Trebesska 1575, Hradec Kralove 500 01, Czech Republic.
- 700 1_
- $a Pavkova, Ivona $u Department of Molecular Pathology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Trebesska 1575, Hradec Kralove 500 01, Czech Republic.
- 700 1_
- $a Stulik, Jiri $u Department of Molecular Pathology, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Trebesska 1575, Hradec Kralove 500 01, Czech Republic.
- 773 0_
- $w MED00188133 $t Pathogens and disease $x 2049-632X $g Roč. 73, č. 8 (2015), s. ftv058
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26253078 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160728111305 $b ABA008
- 999 __
- $a ok $b bmc $g 1155096 $s 944954
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 73 $c 8 $d ftv058 $e 20150806 $i 2049-632X $m Pathogens and disease $n Pathog Dis $x MED00188133
- LZP __
- $a Pubmed-20160722